title: New drugs 2014, part 3.
authors.affiliation: Remington Professor of Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pa.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D014151:Anti-Anxiety Agents / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D001592:Benzyl Alcohols / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D002722:Chlorobenzenes; D017277:Drug Approval; D008453:Maytansine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010879:Piperazines / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines; D013440:Sulfides; D013449:Sulfonamides; D000078784:Vortioxetine
chemical_list: D014151:Anti-Anxiety Agents; D001592:Benzyl Alcohols; D001993:Bronchodilator Agents; D002722:Chlorobenzenes; D010879:Piperazines; D011720:Pyrazoles; D011743:Pyrimidines; D013440:Sulfides; D013449:Sulfonamides; C550468:vilanterol; D008453:Maytansine; D000078784:Vortioxetine; C542595:riociguat; C533860:macitentan